Steglatro for Managing Blood Sugar in Type 2 Diabetes

Image credit: drugs.com

What is Steglatro used for?

Steglatro is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Includes Steglatro side effects, interactions and indications.

What are the side effects of Steglatro?

Here are some details on certain side effects this drug may cause. Steglatro increases the amount of sugar your body gets rid of in your urine. This removes calories from your body. As a result, some people may experience weight loss while taking Steglatro. For some people with type 2 diabetes, weight loss can be a healthy effect.

What is Steglatro (ertugliflozin)?

STEGLATRO is the sodium-glucose co-transporter-2 (SGLT-2) inhibitor available from MSD. STEGLATRO (ertugliflozin) is indicated in adults aged 18 years and older with type 2 diabetes mellitus (T2DM), as an adjunct to diet and exercise to improve glycaemic control: How does STEGLATRO work?

Can Steglatro be used in the EU?

The European Medicines Agency concluded that Steglatro‘s benefits are greater than its risks and it can be authorised for use in the EU. The Agency considered that Steglatro can treat patients with type 2 diabetes on its own and in combination with other diabetes medicines.

What information should I know about Steglatro?

These highlights do not include all the information needed to use STEGLATRO safely and effectively. information for STEGLATRO. STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

How does Steglatro work?

Steglatro is an oral diabetes medicine that helps control blood sugar levels. Ertugliflozin works by helping the kidneys get rid of glucose from your bloodstream. Steglatro is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Steglatro is not for treating type 1 diabetes.

What is the prescribing information for Steglatro?

See full prescribing information for STEGLATRO. STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

What Is Steglatro

1. https://www.drugs.com/steglatro.html
2. https://www.medicalnewstoday.com/articles/drugs-steglatro
3. https://www.webmd.com/drugs/2/drug-174602/steglatro-oral/details
4. https://en.wikipedia.org/wiki/Ertugliflozin
5. https://bnf.nice.org.uk/drugs/ertugliflozin/
6. https://www.medicine.com/drug/steglatro
7. https://www.ema.europa.eu/en/medicines/human/EPAR/steglatro
8. https://www.msdconnect.co.uk/products/steglatro/
9. https://www.medicines.org.uk/emc/files/pil.10099.pdf

Steglatro Information

1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209803s004lbl.pdf
2. https://www.merck.com/product/usa/pi_circulars/s/steglatro/steglatro_mg.pdf